DWM
GILD icon

Darwin Wealth Management’s Gilead Sciences GILD Stock Holding History

Darwin Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Hold
216
– – 0.01% 297
2026
Q1 		$30.2K Sell
216
-4
-2% -$560 0.01% 266
2025
Q4 		$27K Sell
220
-24
-10% -$2.92K 0.01% 273
2025
Q3 		$27.1K Buy
244
+31
+15% +$3.52K 0.01% 266
2025
Q2 		$23.6K Buy
213
+3
+1% +$319 0.01% 262
2025
Q1 		$19.5K Hold
210
– – 0.01% 308
2024
Q4 		$19.5K Buy
210
+1
+0.5% +$90 0.01% 308
2024
Q3 		$17.6K Buy
+209
New +$15.9K ﹤0.01% 326
2020
Q3 		– Sell
-40,463
Closed -$3.11M – 163
2020
Q2 		$3.11M Buy
40,463
+39,951
+7,803% +$3.06M 0.79% 43
2020
Q1 		$38K Buy
+512
New +$35.4K 0.01% 273
2018
Q1 		– Sell
-24,163
Closed -$1.73M – 141
2017
Q4 		$1.73M Buy
+24,163
New +$1.83M 0.74% 54

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Darwin Wealth Management's GILD Position: Q2 2026 in Review

Darwin Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 216 shares worth $27.4K. The position accounts for 0.01% of the portfolio, ranked #297.

Darwin Wealth Management first reported a position in GILD in Q4 2017 and has held it in 11 quarters since. The position peaked at $3.11M in Q2 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Darwin Wealth Management held 216 shares of Gilead Sciences worth $27.4K as of Q2 2026.
  • Darwin Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #297 holding.
  • Darwin Wealth Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 11 quarters since.
  • Darwin Wealth Management's Gilead Sciences position peaked at $3.11M in Q2 2020.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.